Recruiting

Observational Study

Sponsor:

Jazz Pharmaceuticals

Code:

NCT04899947

Conditions

Narcolepsy

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Study Details

Brief summary:

CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed.

The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.

Conditions

Narcolepsy

Study ID

NCT04899947

Start date

Oct 10, 2020

Status verified date

Aug, 2024

Completion date

Oct 1, 2024

Anticipated

Primary completion date

Oct 1, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
  • Age less than 18 years
  • Willing to participate in the Registry and complete the informed consent form
  • Able to participate in English based registry

Exclusion Criteria:

  • Age 18 years or more
  • Fail to complete the informed consent form

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Improve Understanding of Natural History of Pediatric Narcolepsy [ Time Frame: Up to 4 years ]
  • Characterize the Presentation, Identification, and Diagnosis of Narcolepsy in Pediatric Participants [ Time Frame: Up to 4 years ]
  • Understand Treatment Practices and Outcomes Captured by Treatment Regimen and Rational for Changes [ Time Frame: Up to 4 years ]

Central Contacts and Locations

Central contacts

Director Clinical Trial Disclosure & Transparency

2158709177ClinicalTrialDisclosure@JazzPharma.com

Locations

University of Arizona

Recruiting

Tucson, Arizona, United States, 85719

Arkansas Children's Research Institute

Recruiting

Little Rock, Arkansas, United States, 72202

Stanford University

Recruiting

Redwood City, California, United States, 94063

University of California San Diego

Recruiting

San Diego, California, United States, 92093

University of South Florida

Recruiting

Tampa, Florida, United States, 33620

Boston Children's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

St. Luke's Hospital

Recruiting

Chesterfield, Missouri, United States, 63017

Children's Mercy Hospital

Recruiting

Kansas City, Missouri, United States, 64108

Northwell Health

Recruiting

Manhasset, New York, United States, 11030

Cincinnati Children's Hospital Medical Center

Recruiting

Cincinnati, Ohio, United States, 45229

University Hospitals Cleveland Medical Centre (UHCMC)

Recruiting

Cleveland, Ohio, United States, 44106

Ohio Sleep Medicine Institute

Recruiting

Dublin, Ohio, United States, 43017

Geisinger

Recruiting

Danville, Pennsylvania, United States, 17822

Children's Hospital of Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Texas Children's Hospital (Baylor College of Medicine)

Recruiting

Houston, Texas, United States, 77030

Children's Hospital of the King's Daughters

Recruiting

Norfolk, Virginia, United States, 23507

More Information

Sponsor

Jazz Pharmaceuticals

Last update posted

Aug 15, 2024

Last verified

Aug, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Jazz Pharmaceuticals on 2024-08-15.